268 related articles for article (PubMed ID: 21145971)
1. Raised calcium promotes α-synuclein aggregate formation.
Nath S; Goodwin J; Engelborghs Y; Pountney DL
Mol Cell Neurosci; 2011 Feb; 46(2):516-26. PubMed ID: 21145971
[TBL] [Abstract][Full Text] [Related]
2. Raised calcium and oxidative stress cooperatively promote alpha-synuclein aggregate formation.
Goodwin J; Nath S; Engelborghs Y; Pountney DL
Neurochem Int; 2013 Apr; 62(5):703-11. PubMed ID: 23159813
[TBL] [Abstract][Full Text] [Related]
3. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
4. Copper binding regulates intracellular alpha-synuclein localisation, aggregation and toxicity.
Wang X; Moualla D; Wright JA; Brown DR
J Neurochem; 2010 May; 113(3):704-14. PubMed ID: 20141569
[TBL] [Abstract][Full Text] [Related]
5. Dopamine facilitates alpha-synuclein oligomerization in human neuroblastoma SH-SY5Y cells.
Yamakawa K; Izumi Y; Takeuchi H; Yamamoto N; Kume T; Akaike A; Takahashi R; Shimohama S; Sawada H
Biochem Biophys Res Commun; 2010 Jan; 391(1):129-34. PubMed ID: 19900407
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease.
Azeredo da Silveira S; Schneider BL; Cifuentes-Diaz C; Sage D; Abbas-Terki T; Iwatsubo T; Unser M; Aebischer P
Hum Mol Genet; 2009 Mar; 18(5):872-87. PubMed ID: 19074459
[TBL] [Abstract][Full Text] [Related]
7. Mathematical approach to understand the kinetics of alpha-synuclein aggregation: relevance to Parkinson's disease.
Bharathi P; Nagabhushan P; Rao KS
Comput Biol Med; 2008 Oct; 38(10):1084-93. PubMed ID: 18823621
[TBL] [Abstract][Full Text] [Related]
8. [The wild-type alpha-synuclein over-expression to induce the protein aberrant aggregation of alpha-synuclein in HEK293 cells in vitro].
Chen T; Tang BS; Liao XP; Yan XX; Zhang RX; Zhang YH; Tang JG; Cao L; Guo JF; Li J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Feb; 23(1):19-22. PubMed ID: 16456779
[TBL] [Abstract][Full Text] [Related]
9. Controlling the mass action of alpha-synuclein in Parkinson's disease.
Kim C; Lee SJ
J Neurochem; 2008 Oct; 107(2):303-16. PubMed ID: 18691382
[TBL] [Abstract][Full Text] [Related]
10. Selective detection, quantification, and subcellular location of alpha-synuclein aggregates with a protein aggregate filtration assay.
Kramer ML; Behrens C; Schulz-Schaeffer WJ
Biotechniques; 2008 Mar; 44(3):403-11. PubMed ID: 18361794
[TBL] [Abstract][Full Text] [Related]
11. The behavior of alpha-synuclein in neurons.
Fortin DL; Nemani VM; Nakamura K; Edwards RH
Mov Disord; 2010; 25 Suppl 1():S21-6. PubMed ID: 20187244
[TBL] [Abstract][Full Text] [Related]
12. Cytokines disrupt intracellular patterns of Parkinson's disease-associated proteins alpha-synuclein, tau and ubiquitin in cultured glial cells.
Bick RJ; Poindexter BJ; Kott MM; Liang YA; Dinh K; Kaur B; Bick DL; Doursout MF; Schiess MC
Brain Res; 2008 Jun; 1217():203-12. PubMed ID: 18501880
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence imaging of amyloid formation in living cells by a functional, tetracysteine-tagged alpha-synuclein.
Roberti MJ; Bertoncini CW; Klement R; Jares-Erijman EA; Jovin TM
Nat Methods; 2007 Apr; 4(4):345-51. PubMed ID: 17351621
[TBL] [Abstract][Full Text] [Related]
14. Towards multiparametric fluorescent imaging of amyloid formation: studies of a YFP model of alpha-synuclein aggregation.
van Ham TJ; Esposito A; Kumita JR; Hsu ST; Kaminski Schierle GS; Kaminski CF; Dobson CM; Nollen EA; Bertoncini CW
J Mol Biol; 2010 Jan; 395(3):627-42. PubMed ID: 19891973
[TBL] [Abstract][Full Text] [Related]
15. Agrin binds alpha-synuclein and modulates alpha-synuclein fibrillation.
Liu IH; Uversky VN; Munishkina LA; Fink AL; Halfter W; Cole GJ
Glycobiology; 2005 Dec; 15(12):1320-31. PubMed ID: 16037493
[TBL] [Abstract][Full Text] [Related]
16. Pro-apoptotic protein glyceraldehyde-3-phosphate dehydrogenase promotes the formation of Lewy body-like inclusions.
Tsuchiya K; Tajima H; Kuwae T; Takeshima T; Nakano T; Tanaka M; Sunaga K; Fukuhara Y; Nakashima K; Ohama E; Mochizuki H; Mizuno Y; Katsube N; Ishitani R
Eur J Neurosci; 2005 Jan; 21(2):317-26. PubMed ID: 15673432
[TBL] [Abstract][Full Text] [Related]
17. Protein array analysis of oligomerization-induced changes in alpha-synuclein protein-protein interactions points to an interference with Cdc42 effector proteins.
Schnack C; Danzer KM; Hengerer B; Gillardon F
Neuroscience; 2008 Jul; 154(4):1450-7. PubMed ID: 18541383
[TBL] [Abstract][Full Text] [Related]
18. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
19. Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?
Chu Y; Kordower JH
Neurobiol Dis; 2007 Jan; 25(1):134-49. PubMed ID: 17055279
[TBL] [Abstract][Full Text] [Related]
20. The aggregation and fibrillation of alpha-synuclein.
Fink AL
Acc Chem Res; 2006 Sep; 39(9):628-34. PubMed ID: 16981679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
